Select Format:

Select Volume:




Cat. No.




p27, also known as p27Kip1, is a cyclin-dependent kinase inhibitor that binds to and inhibits cyclin-dependent kinases, thereby regulating progression from G1 to S phase. Decreased expression of p27 is linked to poor prognosis in renal-cell carcinoma, colon carcinoma, small breast carcinomas, non-small-cell lung carcinoma, hepatocellular carcinoma, multiple myeloma, lymph node metastases in papillary carcinoma of the thyroid, and is associated with a more aggressive phenotype of carcinoma in the cervix.
  • References
    1. Lloyd RV, et al. Am J Pathol. 1999; 154:313-23.
    2. Migita T, et al. Cancer. 2002; 94:973-9.
    3. Haitel A, et al. Urology. 2001; 58:477-81.
    4. Esposito V, et al. Cancer Res. 1997; 57:3381-5.
    5. Tan P, et al. Cancer Res. 1997; 57:1259-63
    6. Khoo ML, et al. J Clin Endocrinol Metab. 2002; 87:1814-8.
    7. Huang LW, et al. Gynecol Oncol. 2002; 85:524-8.
    8. Ribal MJ, et al. Anticancer Res. 2003; 23:5101-6.
    9. Khoo ML, et al. Arch Otolaryngol Head Neck Surg. 2002; 128:253-7.
    10. Freedland SJ, et al. Urology. 2003; 61:1187-92.
    11. Armengol C, et al. J Hepatol. 2003; 38:591-7.


Clone IHC027
Source Mouse Monoclonal
Positive Control Tonsil
Dilution Range 1:50-1:200